BLFS — BioLife Solutions Balance Sheet
0.000.00%
Last trade - 00:00
- $718.46m
- $709.74m
- $143.27m
- 57
- 31
- 78
- 55
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 6.45 | 90.4 | 69.9 | 19.4 | 35.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.34 | 8.01 | 23.2 | 33.9 | 18.7 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 24.1 | 115 | 126 | 138 | 121 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10.5 | 24.5 | 46.6 | 48.3 | 40.3 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 92.8 | 235 | 554 | 450 | 413 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.67 | 15.6 | 42.7 | 44.6 | 42.2 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 49.4 | 29.6 | 76.2 | 86 | 75.1 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 43.5 | 205 | 478 | 364 | 338 |
Total Liabilities & Shareholders' Equity | 92.8 | 235 | 554 | 450 | 413 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |